logo for Alvogen

Alvogen

Manufacturing · New Jersey, United States · 2,400 Employees

View Company Info for Free

About

Headquarters

10 Bloomfield Ave, Pine Brook, New Jersey, 0705...

Phone Number

(973) 796-3400

Revenue

$717.6 Million

Industry

Pharmaceuticals Healthcare

Highlights

$100M

Total Funding Amount

$100M

Most Recent Funding Amount

1

Number of Funding Rounds

View details

Who is Alvogen

Alvogen, founded in 2009 headquartered in Morristown, New Jersey, operates as a pharmaceutical company. The Company develops, manufactures, and mar kets parallel imported and generic drugs. Alvogen Pharma US serves clients worldwide.Read more

Alvogen's Social MediaPopular SearchesAlvogenAlvogen IncNorwich Pharmaceuticals IncAlvogen Group IncNorwich Pharma ServicesSIC Code 28,283NAICS Code 32,325Show more

Alvogen Org Chart

PhoneEmail
Shekar Poojari

Chief Financial Officer, Alvogen Korea

PhoneEmail
Junseok Lim

Chief Marketing Officer, Scm & Sourcing & Man...

PhoneEmail

PhoneEmail

Is Alvogen your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Similar Companies to Alvogen

Analyze insights from companies similar to Alvogen and make strategic comparisons based on performance, financial data, growth and unique benchmarks.

See more companies
Illustration of an envelope

Alvogen financials insights

Gather financial insights about Alvogen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

Alvogen Employee Growth Rate

Graph showing projected employee growth data for Alvogen

View Alvogen’s full employee growth data

Percentage of growth

1st year Mask

2nd year Mask

Alvogen Tech Stack

A closer look at the technologies used by Alvogen

Most Recent Scoops

Jul 9 2024
Event
Events
Aug 1 2023
Open Position
Jun 5 2023
Partnership
Partnership, Intellectual Property, Logistics / Supply Chain
Nov 7 2022
Open Position
Sep 29 2022
Open Position
See more scoops

Alvogen News & Media

  • NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101

    RADNOR, Pa. and MORRISTOWN, N.J. and TAIPEI, Taiwan, June 05, 2023 (GLOBE NEWSWIRE) -- Lotus Pharmaceuticals (1795:TT; “Lotus”), a multinational pharmaceutical company, Alvogen, a privately owned U.S. based pharmaceuticals company, and NRx Pharmaceuticals Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals or NRx”), a clinical stage biopharmaceutical company, today announced a global collaboration agreement covering the development and commercialization of NRX-101 for suicidal treatment-resistant bipolar
  • Privately Held Alvogen Announces Favorable Ruling on Patents Related to the Company’s Proposed Generic to Xifaxan® for IBS-D

    MORRISTOWN, N.J.--(BUSINESS WIRE)--Alvogen, a privately held pharmaceutical company focused on developing, manufacturing and selling generic and branded products, announced today a favorable district court ruling on multiple patents related to the company’s proposed generic to Xifaxan®, a treatment for irritable bowel syndrome with diarrhea (IBS-D) in adults. “We are extremely pleased with the district court’s decision, which brings us one step closer to bringing a more affordable alternative t
  • PTT raises stake in Taiwan firm - The Bangkok Post

    National oil and gas conglomerate PTT has taken a significant step into the pharmaceutical sector by teaming up with the Aztiq Fund to buy out Alvogen Emerging Markets Holdings (AEMH), increasing PTT's shareholding in Taiwan-based Lotus Pharmaceutical Co to 37% from 6.6%.
  • Aztiq Buys 17% Stake in Alvogen US

    REYKJAVIK, Iceland--(BUSINESS WIRE)--Aztiq Pharma Partners, a private equity fund led by Róbert Wessman, today announced that it has completed a US$100 million financing to purchase a newly issued share equity in Alvogen US. Morgan Stanley led the financing, which was subscribed by international institutional investors. The capital was used by Aztiq to buy a 17% stake in Alvogen US, at Fora pre-money valuation of US$ 350 million. “The new equity will allow Alvogen's generic business
Read more news

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Frequently Asked Questions Regarding Alvogen

Where is Alvogen located?
Alvogen's headquarters are located at 10 Bloomfield Ave, Pine Brook, New Jersey, 07058, United States
What is Alvogen's phone number?
Alvogen's phone number is (973) 796-3400
What is Alvogen's official website?
Alvogen's official website is www.alvogen.com
What is Alvogen's Revenue?
Alvogen's revenue is $717.6 Million
What is Alvogen's SIC code?
Alvogen's SIC: 28,283
What is Alvogen's NAICS code?
Alvogen's NAICS: 32,325
How many employees does Alvogen have?
Alvogen has 2,400 employees
What industry does Alvogen belong to?
Alvogen is in the industry of: Pharmaceuticals, Healthcare
What is Alvogen competition?
Alvogen top competitors include: Par Pharmaceutical, Amneal Pharmaceuticals, Lannett, Bausch Health
What companies has Alvogen acquired?
Alvogen has acquired the companies: Norwich Eaton Pharmaceuticals, Dream Pharma, Zentiva.co.uk, Omega Bittner
What technology does Alvogen use?
Some of the popular technologies that Alvogen uses are: Microsoft SharePoint, Prototype, prismic.io, AppRiver
Who is the CFO of Alvogen?
Alvogen's CFO is Shekar Poojari
How do I contact Alvogen?
Alvogen contact info: Phone number: (973) 796-3400 Website: www.alvogen.com
What does Alvogen do?

Alvogen, founded in 2009 headquartered in Morristown, New Jersey, operates as a pharmaceutical company. The Company develops, manufactures, and markets parallel imported and generic drugs. Alvogen Pharma US serves clients worldwide.... Read More

What are Alvogen social media links?
Alvogen Linkedin page Alvogen Twitter page Alvogen Facebook page
How much funding has Alvogen raised to date?
Alvogen has raised $100 Million in 1 funding round
When was the last funding round for Alvogen?
Alvogen closed its last funding round on Jun 30, 2021 with the amount of $100 Million
Is Alvogen a public company?
Alvogen is private company therefore does not currently have an official ticker symbol
See more information about Alvogen

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.